Here are five updates on GI companies from the past week.
The FDA permitted Wilson-Cook Medical to market Hemospray, a new endoscopic device for the treatment of gastrointestinal bleeding.
The FDA approved Salix Pharmaceuticals' Plenvu lower-volume polyethylene glycol-based bowel preparation.
Libertyville-based GI Partners of Illinois and Cumming, Ga.-based GI North both switched to the gGastro EHR system by gMed, a Modernizing Medicine company.
Olympus entered a co-development agreement with ai4gi to offer the artificial intelligence solution for real-time clinical decision support during screening and surveillance colonoscopy.
GI Supply's Spot Ex Endoscopic Tattoo received CE mark approval and launched in Europe.